An emerging area of preventive medicine focused on slowing biological aging and extending healthspan. It has no recognized specialty board in the United States.

Longevity medicine applies the science of aging, sometimes called geroscience, to clinical care. Instead of waiting for disease, it tries to measure biological aging and intervene earlier through risk factor management, lifestyle change, and in some practices off-label drugs such as rapamycin or metformin.

In practice most of what it delivers is established preventive medicine: cholesterol, blood pressure, and blood sugar control, strength and cardiorespiratory fitness, sleep, and not smoking. The newer layer, biological age clocks and aging-targeted drugs, rests on early human evidence and has not yet been shown to change outcomes in a trial.

Because there is no board certification, anyone can describe a practice as longevity medicine. The term covers academic geroscience clinics and infusion bars alike. The distinguishing question is whether a program's interventions have human outcome data or only a mechanistic story.

Research publication: Definitions reflect current research status and are for educational purposes. This is not medical advice.